Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Possible Role of Glivec in Patients With Tumor Cells Positive for C-kit or Platelet Derived Growth Factor Receptor (PDGFR); a Multi Center Study.

NCT00159016 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00159016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00159016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Possible Role of Glivec in Patients With Tumor Cells Positive for C-kit or Platelet Derived Growth Factor Receptor (PDGFR); a Multi Center Study.
Lead sponsor
Hadassah Medical Organization
Phase
Phase 2
Overall status
Withdrawn
Start date
August 31, 2002
Completion date
September 30, 2005
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic solid tumors.